Smoking Cessation Program in the Preadmission Clinic
Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, placebo-controlled clinical trial which evaluates
the efficacy of preoperative smoking counseling and varenicline (a medication approved by
Health Canada and FDA for quitting smoking) to provide long term smoking cessation (i.e.,
abstinence for at least one year) in surgical patients.
The primary hypothesis is as follows: "A significant percentage of surgical patients will be
receptive to smoking cessation interventions in the pre-admission clinic and will refrain
from smoking at 24 and 52 weeks after starting the treatment." The secondary hypothesis is as
follows: "Patients who receive interventions but do not quit smoking will have reduced number
of cigarettes consumed/day or improved their readiness to quit smoking at 24 and 52 weeks
after starting the treatment."